Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 3/20 | 0.65 |
| ▸ | ADH1A | P07327 | 3/20 | 0.65 |
| ▸ | ADH7 | P40394 | 3/20 | 0.65 |
| ▸ | ADH1C | P00326 | 2/20 | 0.65 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.62 |
| ▸ | ADH4 | P08319 | 1/20 | 0.62 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1963312 | 0.88 | ADH1B (0.85) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL11397515 | 0.88 | ADH1B (0.81) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL5254384 | 0.85 | ADH1B (0.90) | ADH1BADH1AADH7ADH1CEPHX1 | |
| Iodide SCHEMBL6053668 | 0.85 | ADH1B (0.70) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL20686937 | 0.84 | ADH1B (0.60) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL7021636 | 0.83 | ADH1B (0.90) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL5256142 | 0.83 | ADH1B (0.90) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL9921466 | 0.82 | ADH1B (0.74) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL5254834 | 0.82 | — | — | |
| SCHEMBL9921470 | 0.82 | ADH1B (0.74) | ADH1BADH1AADH7ADH1CEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12071498-B2 | Radically polymerizable compositions | Polynt Composites USA, Inc. (US) | 2024-08-27 | — | — | US | disclosed |
| US-20230257500-A1 | RADICALLY POLYMERIZABLE COMPOSITIONS | BNY MELLON CORPORATE TRUSTEE SERVICES LIMITED, AS SECURITY AGENT (GB) | 2023-08-17 | — | — | US | disclosed |
| US-11518834-B2 | Radically polymerizable compositions | Polynt Composites USA, Inc. (US) | 2022-12-06 | — | — | US | disclosed |
| EP-3077467-B1 | DRIER COMPOSITION AND USE THEREOF | PPG EUROPE B V (NL) | 2022-11-02 | — | — | EP | disclosed |
| EP-3906265-A1 | RADICALLY POLYMERIZABLE COMPOSITIONS | Polynt Composites USA Inc. (US) | 2021-11-10 | — | — | EP | disclosed |
| WO-2020142632-A1 | RADICALLY POLYMERIZABLE COMPOSITIONS | Polynt Composites USA, Inc. (US) | 2020-07-09 | — | — | WO | disclosed |
| EP-2600904-A1 | ARTIFICIAL CELLS | Searete LLC (US) | 2013-06-12 | — | — | EP | disclosed |
| WO-2012018389-A1 | ARTIFICIAL CELLS | SEARETE LLC (US) | 2012-02-09 | — | — | WO | disclosed |
| EP-1670512-A2 | SINGLET OXYGEN PHOTOSENSITIZERS ACTIVATED BY TARGET BINDING ENHANCING THE SELECTIVITY OF TARGETED PDT AGENTS | Light Sciences Corporation (US) | 2006-06-21 | — | — | EP | disclosed |
| WO-2005030254-A2 | CONJUGATES FOR PHOTODYNAMIC THERAPY | LIGHT SCIENCES CORPORATION (US) | 2005-04-07 | — | — | WO | disclosed |
| WO-2003007944-A1 | TREATMENT OF MACULAR EDEMA WITH PHOTODYNAMIC THERAPY | QLT, INC. (CA) | 2003-01-30 | — | — | WO | disclosed |
| WO-2002083097-A2 | DRUG DELIVERY SYSTEM FOR HYDROPHOBIC DRUGS | QLT INC. (CA) | 2002-10-24 | — | — | WO | disclosed |
| WO-2002064163-A2 | REDUCTION OR PREVENTION OF PDT RELATED INFLAMMATION | QLT INC. (CA) | 2002-08-22 | — | — | WO | disclosed |
| WO-2002062386-A2 | PHOTODYNAMIC THERAPY OF OCCULT CHOROIDAL NEOVASCULARIZATION LINKED TO AGE-RELATED MACULAR DEGENERATION | QLT INC. (CA) | 2002-08-15 | — | — | WO | disclosed |
| WO-2002062384-A2 | REDUCED FLUENCE RATE PDT | QLT INC. (CA) | 2002-08-15 | — | — | WO | disclosed |
| WO-2002062385-A2 | METHOD TO PREVENT VISION LOSS | QLT, INC. (CA) | 2002-08-15 | — | — | WO | disclosed |
| EP-1229937-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT Inc. (CA) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001085213-A2 | SUPPORTS FOR PHOTOSENSITIZER FORMULATIONS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001035996-A2 | USE OF PDT TO INHIBIT INTIMAL HYPERPLASIA | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |
| WO-2001035997-A2 | USE OF LOW-DOSE PDT TO INHIBIT RESTENOSIS | QLT INC. (CA) | 2001-05-25 | — | — | WO | disclosed |